secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001493152-25-026247
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix board reconstituted; four directors retire, five new directors elected, LTIP share pool expanded
--------------------------------------------------------------------------------

- Christopher Fashek, Thomas Mika, Martin Goldstein, Brian Murphy retired immediately before the 2025 Annual Meeting for personal reasons; no disagreement with Company.
- Stockholders elected Doron Besser, David Johnson, Zeev Rotstein, Nino Pionati, Alison Geiger Burgett as directors for one-year terms.
- First Amendment to 2024 Long-Term Incentive Plan approved; shares reserved increased by 1,200,000 to 1,205,454 shares.
- Share issuance proposal under Nasdaq Rule 5635(d) approved, covering convertible preferred stock and warrants from July 2025 private placement.
- Kost Forer Gabbay & Kasierer (EY) ratified as independent auditor for FY 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225026247/0001493152-25-026247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225026247/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-026247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer